Regeneron Pharmaceuticals News - REGN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  6.56 1.94% 344.95 349.86 338.71 340.95 338.39 14:48:45
more quote information »

Recent News

Date Time Source Heading
11/13/201916:12EDGARStatement of Changes in Beneficial Ownership (4)
11/12/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
11/12/201907:30PRNUSRegeneron Announces Upcoming Investor Conference..
11/08/201917:03EDGARStatement of Changes in Beneficial Ownership (4)
11/06/201909:00PRNUSRegeneron to Report Results from CD20xCD3 and BCMAxCD3..
11/06/201907:00PRNUSRegeneron and Vyriad Announce Strategic Agreement for..
11/05/201913:29DJNRegeneron Pharmaceuticals Up Over 9%, on Pace for Largest..
11/05/201908:25DJNRegeneron Pharmaceuticals Board Approves $1 Billion Buyback
11/05/201907:49EDGARQuarterly Report (10-q)
11/05/201907:37EDGARCurrent Report Filing (8-k)
11/05/201907:14DJNRegeneron Pharmaceuticals Reports Higher 3Q Profit
11/05/201906:40PRNUSRegeneron Provides Updates on Phase 3 Libtayo® (cemiplimab)..
11/05/201906:30PRNUSRegeneron Reports Third Quarter 2019 Financial and Operating..
10/29/201909:12DJNSanofi, Regeneron Gets EU OK for Expanded Dupixent Use
10/29/201908:15PRNUSDupixent® (dupilumab) Now Approved in European Union for..
10/25/201907:05PRNUSRegeneron Ranked #2 in Science Magazine's Top Biopharma..
10/25/201907:00PRNUSRegeneron Colleagues Support 150 Community Organizations..
10/18/201908:30PRNUSRegeneron Announces Upcoming Investor Conference..
10/10/201909:30PRNUSRegeneron to Report Third Quarter 2019 Financial and..
10/08/201914:00EDGARConfidential Treatment Order (ct Order)
9/20/201907:22DJNRegeneron, Sanofi Get Positive CHMP Opinion for Dupixent
9/20/201906:59PRNUSThe Lancet Publishes Results from Two Positive Phase 3..
9/20/201906:44PRNUSCHMP Recommends Approval of Dupixent® (dupilumab) for Severe..
9/18/201906:59PRNUSEducational Campaign Helps Teens and Their Caregivers Tackle..
9/17/201907:00PRNUSRegeneron Debuts on Prestigious Dow Jones Sustainability..
9/12/201917:01EDGARStatement of Changes in Beneficial Ownership (4)
8/28/201918:34DJNU.S. Federal Judge Rules for Sanofi, Regeneron in..
8/28/201916:56PRNUSU.S. District Court Invalidates Amgen Patent Claims..
8/15/201909:30PRNUSRegeneron Announces Upcoming Investor Conference..
8/14/201907:00PRNUSRegeneron Announces Positive Topline Results from Phase 3..
8/13/201907:00PRNUSFDA Approves EYLEA® (aflibercept) Injection Prefilled..
8/12/201915:16DJNTwo Experimental Ebola Drugs Reduce Mortality Rate
8/12/201910:01PRNUSPALM Ebola Clinical Trial Stopped Early as Regeneron's..
8/06/201909:57DJNRegeneron, Sanofi: Dupixent Meets Main Endpoints in Children..
8/06/201909:22DJNRegeneron, Sanofi Get EC OK for Dupixent in Adolescents with..
8/06/201908:13DJNRegeneron Lowers Capital Expenditure Guidance, Changes Other..
8/06/201907:56EDGARQuarterly Report (10-q)
8/06/201907:36EDGARCurrent Report Filing (8-k)
8/06/201907:27DJNRegeneron's Profit Falls as Expenses Spike
8/06/201906:30PRNUSRegeneron Reports Second Quarter 2019 Financial and..
8/06/201901:04PRNUSDupixent® (dupilumab) Showed Positive Topline Results in..
8/06/201900:59PRNUSDupixent® (dupilumab) Approved by European Commission for..
7/18/201907:30PRNUSRegeneron Announces the 2019 Winners of the Regeneron Prize..
7/09/201917:37DJNDrugmakers Rise After Trump Pricing Rule Is Blocked
7/09/201913:58DJNDrugmakers Rise After Trump Pricing Rule Is Blocked
7/08/201909:30PRNUSRegeneron to Report Second Quarter 2019 Financial and..
7/01/201910:00PRNUSLibtayo® (cemiplimab) Approved for Advanced Cutaneous..
6/28/201908:03DJNCommittee Recommends Approval for Dermatitis Treatment Be..
6/28/201906:59PRNUSCHMP Recommends Approval of Dupixent® (dupilumab) for..
6/26/201914:30DJNFDA Approves Sanofi, Regeneron Treatment for Chronic..
See more news about this stock »


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.